First Time Loading...

Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392

Watchlist Manager
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Logo
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Watchlist
Price: 68.65 CNY -2.25% Market Closed
Updated: May 8, 2024
Section:
 

Relative Value

The Relative Value of one Beijing Wantai Biological Pharmacy Enterprise Co Ltd stock under the Base Case scenario is 129.51 CNY. Compared to the current market price of 68.65 CNY, Beijing Wantai Biological Pharmacy Enterprise Co Ltd is Undervalued by 47%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
129.51 CNY
Undervaluation 47%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

15.8
P/S
P/S
Price to Sales
15.8
vs History
45
vs Industry
38
Median 3Y
15.5
Median 5Y
15.5
Industry
8.3
Forward
8.7
More Details
69.7
P/E
P/E
Price to Earnings
69.7
vs History
35
vs Industry
3
Median 3Y
46.4
Median 5Y
46.4
Industry
26.8
Forward
24.3
More Details
56.5
P/OCF
P/OCF
Price to OCF
56.5
vs History
49
vs Industry
3
Median 3Y
55
Median 5Y
56.2
Industry
23.3
More Details
208.8
P/FCFE
P/FCFE
Price to FCFE
208.8
vs History
39
vs Industry
1
Median 3Y
129.2
Median 5Y
168.5
Industry
21.4
More Details
6.8
P/B
P/B
Price to Book Value
6.8
vs History
74
vs Industry
12
Median 3Y
13
Median 5Y
14
Industry
2.6
More Details
14.7
EV/S
EV/S
Enterprise Value to Sales
14.7
vs History
45
vs Industry
33
Median 3Y
14.6
Median 5Y
14.6
Industry
7.5
Forward
8.1
More Details
17.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
17.9
vs History
45
vs Industry
28
Median 3Y
17.6
Median 5Y
17.6
Industry
9.2
More Details
57.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
57.6
vs History
35
vs Industry
2
Median 3Y
38.8
Median 5Y
38.8
Industry
4.5
Forward
17
More Details
57.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
57.6
vs History
35
vs Industry
2
Median 3Y
38.8
Median 5Y
38.8
Industry
4.4
Forward
18.9
More Details
52.7
EV/OCF
EV/OCF
Enterprise Value to OCF
52.7
vs History
50
vs Industry
3
Median 3Y
51.6
Median 5Y
54.3
Industry
5.6
More Details
214.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
214.1
vs History
41
vs Industry
1
Median 3Y
158.7
Median 5Y
209.9
Industry
3.4
More Details
8.8
EV/IC
EV/IC
Enterprise Value to IC
8.8
vs History
74
vs Industry
25
Median 3Y
16.9
Median 5Y
18.2
Industry
5
More Details

Multiples Across Competitors

Competitors Multiples
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
86.9B CNY 15.8 69.7 57.6 57.6
US
Abbvie Inc
NYSE:ABBV
282.8B USD 5.2 58.7 12.8 19.5
US
Amgen Inc
NASDAQ:AMGN
163.1B USD 5.5 43.4 18.4 30.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
108.8B USD 11 30 24.2 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
105.5B USD 8.1 27.3 22.1 24.5
AU
CSL Ltd
ASX:CSL
135.1B AUD 6.3 36 21.8 27
US
Gilead Sciences Inc
NASDAQ:GILD
81B USD 3 167.4 6.7 8.8
US
Moderna Inc
NASDAQ:MRNA
46.5B USD 9 -7.8 -8.5 -7.5
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
32.1B USD 3.3 27.5 14.1 17.6
KR
Celltrion Inc
KRX:068270
40.3T KRW 18.5 75.3 46 63.4

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.